Luxembourg vs Southern Africa: Proportion of the target population who received a 3rd dose of
Luxembourg
97.0%
in 2024
Southern Africa
81.0%
in 2024
Luxembourg rank
11th
Southern Africa rank
12th
Proportion of the target population who received a 3rd dose of over time
- Luxembourg
- Southern Africa
How they compare
Luxembourg currently reports 97.0% against 81.0% in Southern Africa, a difference of 16.0%.
That makes Luxembourg's figure about 1.2 times Southern Africa's.
Across all 16 years both countries report, Luxembourg has been ahead every year.
Luxembourg ranks 11th and Southern Africa ranks 12th of 157 countries.
Luxembourg has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Luxembourg | Southern Africa | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 86.0% | 8.0% | 78.0% | Luxembourg |
| 2010s | 93.4% | 72.0% | 21.4% | Luxembourg |
| 2020s | 96.6% | 84.2% | 12.4% | Luxembourg |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received a 3rd dose of, Luxembourg or Southern Africa?
- Luxembourg, at 97.0% against 81.0% in Southern Africa as of 2024.
- What is the difference in proportion of the target population who received a 3rd dose of between Luxembourg and Southern Africa?
- 16.0%, with Luxembourg ahead.
- How many years of comparable data are there for Luxembourg and Southern Africa?
- 16 years are reported by both, from 2009 to 2024.
- How do Luxembourg and Southern Africa rank globally for proportion of the target population who received a 3rd dose of?
- Luxembourg ranks 11th and Southern Africa ranks 12th of 157 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.